Pitavastatin: focus on safety and drug interactions
Pitavastatin is a drug from the group of HMG-CoA reductase inhibitors, which has good lipid-lowering efficacy and has no significant effect on the risk of diabetes mellitus. This drug is non significantly metabolized by the P450 cytochrome system, which minimizes the risk of possible drug-drug inter...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Concilium Medicum
2021-05-01
|
| Serija: | КардиоСоматика |
| Teme: | |
| Online pristup: | https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/71039/51893 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|